Globeflex Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-21,387
Closed -$2.68M 498
2020
Q4
$2.68M Buy
21,387
+53
+0.2% +$5.93K 0.57% 32
2020
Q3
$2.16M Sell
21,334
-5,201
-20% -$530K 0.57% 28
2020
Q2
$2.58M Sell
26,535
-4,892
-16% -$455K 0.66% 19
2020
Q1
$2.61M Sell
31,427
-3,672
-10% -$358K 0.8% 11
2019
Q4
$3.9M Sell
35,099
-995
-3% -$102K 0.73% 16
2019
Q3
$3.58M Sell
36,094
-1,511
-4% -$150K 0.78% 15
2019
Q2
$3.73M Sell
37,605
-183
-0.5% -$17.5K 0.78% 17
2019
Q1
$4.17M Sell
37,788
-2,529
-6% -$264K 0.88% 11
2018
Q4
$3.71M Sell
40,317
-853
-2% -$86.3K 0.88% 8
2018
Q3
$4.54M Sell
41,170
-336
-0.8% -$35K 0.89% 6
2018
Q2
$3.88M Sell
41,506
-3,300
-7% -$284K 0.79% 8
2018
Q1
$3.72M Buy
44,806
+8,500
+23% +$755K 0.79% 8
2017
Q4
$3.31M Sell
36,306
-1,200
-3% -$99.8K 0.92% 5
2017
Q3
$2.86M Sell
37,506
-9,600
-20% -$726K 0.81% 11
2017
Q2
$3.53M Buy
47,106
+18,000
+62% +$1.25M 0.87% 8
2017
Q1
$1.9M Buy
+29,106
New +$1.71M 0.45% 46
2016
Q2
Sell
-13,700
Closed -$586K 545
2016
Q1
$586K Hold
13,700
0.16% 207
2015
Q4
$620K Hold
13,700
0.17% 207
2015
Q3
$532K Buy
+13,700
New +$549K 0.11% 282

Other funds holding PRAH

Globeflex Capital's PRAH Position: Q1 2021 in Review

Globeflex Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 21,387 shares — an estimated $2.68M sold.

Globeflex Capital first reported a position in PRAH in Q3 2015 and held it in 19 quarters. The position peaked at $4.54M in Q3 2018. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Globeflex Capital reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Globeflex Capital sold 21,387 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $2.68M.
  • Globeflex Capital first reported a position in PRA Health Sciences, Inc. in Q3 2015 and held it in 19 quarters.
  • Globeflex Capital's PRA Health Sciences, Inc. position peaked at $4.54M in Q3 2018.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Globeflex Capital's 13F filing for Q1 2021, filed 14 May 2021.